Back to Search

ABUS

Arbutus Biopharma Corporation Common Stock
Data: 2026-10-02
$4.45
Price
-2.41%
Change
$5.45
52W High
$3.50
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options
Analyzing positioning… Options positioning — based on yesterday's biggest open-interest changes See the chart Institutional flows
Track record
signal day → next-day price move
Quick Stats
Oct 02, 2026

36.2

AI Score

AVOID NEW MONEY

1.2

Volume Ratio

Nov 12, 2026

Next Earnings

13

+ve Days (30d)

15

-ve Days (30d)

ABUS Price vs Max Options Open Interest

How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.

ABUS Max Change In Options Open Interest

How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.

ABUS Options - Sort by Max open Interest (near term)

4th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ABUS Daily Out of Money Options - Sort by Max open Interest (near term)

4th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ABUS Daily In the Money Options - Sort by Max open Interest (near term)

4th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ABUS Most Active Options by Volume(near term)

4th October 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track
ABUS Technical Chart Pro Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select an indicator above — it will be added as a pane under the price chart with aligned dates.

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABUS Stock Summary

Last updated Oct 02, 2026

ABUS is currently trading at $4.45, positioned below its 200-day moving average of $4.54, suggesting bearish momentum. The stock has a 52-week range of $3.5 to $5.45.

Technical Analysis: The 50-day moving average stands at $4.83, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 28.049, suggesting the stock is oversold and potentially undervalued.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.331, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ABUS at 36.2/100 with a AVOID NEW MONEY recommendation.

ABUS (Arbutus Biopharma Corporation Common Stock) Indicators

Last updated Oct 02, 2026

Indicator Value
RSI(14) 28.049
CMF (20) -0.331
ROC (10) -11.178
ADX (14) 23.805
Indicator Value
MACD (12,26,9) -0.091
AROONOSC (14) -100.0
WILLAMS %R (14) -90.323
MFI (14) 29.919

ABUS Candlestick Patterns

No validated candlestick patterns fired for ABUS in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.

Arbutus Biopharma Corporation Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

ABUS Moving Averages Analysis

ABUS (Arbutus Biopharma Corporation Common Stock) Simple Moving Averages

Moving Averages are last updated Oct 02, 2026

Days MA
10 4.79
20 4.95
30 5.01
50 4.83
100 4.67
200 4.54

ABUS Fundamental Analysis

P/E (Forward) 10.2459
P/E (Trailing) 6.08
Market Cap ($) 903.4 million
Earnings/Share ($) 0.75
Net Profit Margin (%) 0.8423
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.027
EPS Estimate Next Year ($) -0.111
WallStreet Target Price ($) 5.36
Most Recent Quarter

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.